Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-11

Clinical Trial Update: Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating the effect of tocilizumab on the cellular immune response to influenza vaccination in patients with rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actemra (tocilizumab)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Rheumatoid Arthritis, Cellular Immune Response | Phase 4 | Status: UNKNOWN